Outcomes of Allogeneic Hematopoietic Cell Transplantation After Bispecific Antibodies in ...

Retrieved on: 2024-01-02 17:08:56

Tags for this article:

Lymphoma

Cancer immunotherapy

Monoclonal antibodies

Non-Hodgkin lymphoma

CAR T cell

Gene therapy

Bispecific monoclonal antibody

Odronextamab

CD20

David G. Maloney

Primary cutaneous diffuse large B-cell lymphoma, leg type

Click the tags to see associated articles and topics

Outcomes of Allogeneic Hematopoietic Cell Transplantation After Bispecific Antibodies in .... View article details on HISWAI: https://www.cancernetwork.com/view/outcomes-of-allogeneic-hematopoietic-cell-transplantation-after-bispecific-antibodies-in-non-hodgkin-lymphomas

Excerpt

... antibodies therapy in patients with relapsed/refractory B-cell lymphomas . ... This broad area includes such agents as monoclonal antibodies ...

Article found on: www.cancernetwork.com

View Original Article